According to statistics, Wuhan Biological Sample Bank Co., Ltd. was established on 2019-0/-31with a registered capital of 300 million RMB and 59 participants. Is a national high-tech enterprise focusing on pharmaceutical manufacturing. The company has been awarded the qualifications and honors of "National High-tech Enterprise", "National Public Service Demonstration Platform for Small and Medium-sized Enterprises" and "National Public Service Demonstration Platform for Small and Medium-sized Enterprises".
In terms of intellectual property rights, Wuhan Biological Sample Bank Co., Ltd. owns software copyright 3 1 and patent information 18. In addition, Wuhan Biological Sample Bank Co., Ltd. also invested in two foreign enterprises, directly holding 1 enterprise.